UK revokes Valneva's IXCHIQ marketing authorization after benefit-risk review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to UK revokes Valneva's IXCHIQ marketing authorization after benefit-risk review

Valneva Provides Update on IXCHIQ® in the United Kingdom

October 7, 2026 4:00 PM EDT

Lyon (France), October 07, 2026  Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for travelers by the United Kingdoms (UK) Commission on Human Medicines (CHM), the UK marketing authorization for IXCHIQ® has been revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). The decision was based on a review of previous safety data... More